A detailed history of Smith, Moore & Co. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Smith, Moore & Co. holds 1,871 shares of BDX stock, worth $425,989. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,871
Previous 1,870 0.05%
Holding current value
$425,989
Previous $437,000 3.2%
% of portfolio
0.04%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$221.47 - $242.41 $221 - $242
1 Added 0.05%
1,871 $451,000
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $42,988 - $47,018
191 Added 11.38%
1,870 $437,000
Q1 2024

May 10, 2024

SELL
$233.45 - $247.73 $233 - $247
-1 Reduced 0.06%
1,679 $415,000
Q4 2023

Feb 13, 2024

SELL
$232.24 - $267.23 $31,584 - $36,343
-136 Reduced 7.49%
1,680 $409,000
Q3 2023

Nov 14, 2023

BUY
$254.9 - $283.59 $254 - $283
1 Added 0.06%
1,816 $469,000
Q2 2023

Aug 11, 2023

SELL
$238.39 - $265.32 $3,814 - $4,245
-16 Reduced 0.87%
1,815 $479,000
Q1 2023

May 12, 2023

BUY
$229.71 - $259.35 $229 - $259
1 Added 0.05%
1,831 $453,000
Q4 2022

Feb 13, 2023

BUY
$218.29 - $256.91 $218 - $256
1 Added 0.05%
1,830 $465,000
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $51 - $264
1 Added 0.05%
1,829 $407,000
Q2 2022

Aug 12, 2022

BUY
$234.74 - $275.42 $1,173 - $1,377
5 Added 0.27%
1,828 $451,000
Q1 2022

May 12, 2022

SELL
$243.64 - $270.48 $6,821 - $7,573
-28 Reduced 1.51%
1,823 $485,000
Q4 2021

Feb 08, 2022

SELL
$230.08 - $250.94 $3,221 - $3,513
-14 Reduced 0.75%
1,851 $466,000
Q3 2021

Nov 12, 2021

SELL
$232.72 - $256.47 $11,403 - $12,567
-49 Reduced 2.56%
1,865 $458,000
Q2 2021

Aug 10, 2021

SELL
$232.65 - $254.58 $47,460 - $51,934
-204 Reduced 9.63%
1,914 $466,000
Q1 2021

May 14, 2021

SELL
$232.09 - $256.88 $25,529 - $28,256
-110 Reduced 4.94%
2,118 $515,000
Q4 2020

Feb 16, 2021

SELL
$221.92 - $245.94 $101,417 - $112,394
-457 Reduced 17.02%
2,228 $558,000
Q3 2020

Nov 12, 2020

SELL
$215.77 - $276.76 $53,726 - $68,913
-249 Reduced 8.49%
2,685 $625,000
Q2 2020

Aug 10, 2020

BUY
$219.9 - $263.41 $397,139 - $475,718
1,806 Added 160.11%
2,934 $702,000
Q1 2020

May 15, 2020

BUY
$195.69 - $279.01 $35,615 - $50,779
182 Added 19.24%
1,128 $259,000
Q4 2019

Feb 07, 2020

BUY
$236.45 - $266.82 $236 - $266
1 Added 0.11%
946 $257,000
Q3 2019

Nov 07, 2019

SELL
$230.58 - $256.08 $80,703 - $89,628
-350 Reduced 27.03%
945 $239,000
Q2 2019

Aug 15, 2019

BUY
$217.4 - $246.08 $13,261 - $15,010
61 Added 4.94%
1,295 $326,000
Q1 2019

May 07, 2019

SELL
$206.05 - $248.17 $403,651 - $486,165
-1,959 Reduced 61.35%
1,234 $308,000
Q4 2018

Feb 15, 2019

SELL
$204.73 - $257.93 $8,189 - $10,317
-40 Reduced 1.24%
3,193 $720,000
Q3 2018

Nov 15, 2018

BUY
$233.07 - $256.0 $21,908 - $24,064
94 Added 2.99%
3,233 $844,000
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $7,907 - $8,886
-38 Reduced 1.2%
3,139 $752,000
Q1 2018

May 14, 2018

BUY
$205.46 - $240.27 $263,194 - $307,785
1,281 Added 67.56%
3,177 $689,000
Q4 2017

Feb 09, 2018

SELL
$189.0 - $222.64 $16,254 - $19,147
-86 Reduced 4.34%
1,896 $406,000
Q3 2017

Nov 02, 2017

BUY
$186.89 - $198.9 $370,415 - $394,219
1,982
1,982 $388,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Smith, Moore & Co. Portfolio

Follow Smith, Moore & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.